Zeng D - Search Results

1

Identifying a Novel Eight-NK Cell-related Gene Signature for Ovarian Cancer Prognosis Prediction.

Li N, Yu K, Huang D, Zhou H, Zeng D. Li N, et al. Among authors: zeng d. Curr Med Chem. 2024;31(12):1578-1594. doi: 10.2174/0929867331666230831101847. Curr Med Chem. 2024. PMID: 37650393

2

Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.

Li N, Yu K, Lin Z, Zeng D. Li N, et al. Among authors: zeng d. Comb Chem High Throughput Screen. 2021;24(2):233-245. doi: 10.2174/1386207323999200729113641. Comb Chem High Throughput Screen. 2021. PMID: 32729416

3

Identifying a cervical cancer survival signature based on mRNA expression and genome-wide copy number variations.

Li N, Yu K, Lin Z, Zeng D. Li N, et al. Among authors: zeng d. Exp Biol Med (Maywood). 2022 Feb;247(3):207-220. doi: 10.1177/15353702211053580. Epub 2021 Oct 21. Exp Biol Med (Maywood). 2022. PMID: 34674573 Free PMC article.

4

Identifying immune subtypes of uterine corpus endometrial carcinoma and a four-paired-lncRNA signature with immune-related lncRNAs.

Li N, Yu K, Lin Z, Zeng D. Li N, et al. Among authors: zeng d. Exp Biol Med (Maywood). 2022 Feb;247(3):221-236. doi: 10.1177/15353702211053588. Epub 2021 Oct 27. Exp Biol Med (Maywood). 2022. PMID: 34704492 Free PMC article.

5

Development of a Novel Immune Subtyping System Expanded with Immune Landscape and an 11-Gene Signature for Predicting Prostate Cancer Survival.

Li N, Yu K, Lin Z, Zeng D. Li N, et al. Among authors: zeng d. J Oncol. 2022 Feb 16;2022:1183173. doi: 10.1155/2022/1183173. eCollection 2022. J Oncol. 2022. PMID: 35222640 Free PMC article.

6

Molecular Characterization of Cuproptosis-related lncRNAs: Defining Molecular Subtypes and a Prognostic Signature of Ovarian Cancer.

Li N, Yu K, Huang D, Li S, Zeng D, Li J, Fan L. Li N, et al. Among authors: zeng d. Biol Trace Elem Res. 2024 Apr;202(4):1428-1445. doi: 10.1007/s12011-023-03780-3. Epub 2023 Aug 2. Biol Trace Elem Res. 2024. PMID: 37528285

7

Gene therapy for human ovarian cancer cells using efficient expression of Fas gene combined with γδT cells.

Lin J, Zeng D, He H, Tan G, Lan Y, Jiang F, Sheng S. Lin J, et al. Among authors: zeng d. Mol Med Rep. 2017 Oct;16(4):3791-3798. doi: 10.3892/mmr.2017.7107. Epub 2017 Jul 27. Mol Med Rep. 2017. PMID: 28765933

8

Exploration the global single-cell ecological landscape of adenomyosis-related cell clusters by single-cell RNA sequencing.

Lin J, Liu L, Zheng F, Chen S, Yang W, Li J, Mo S, Zeng DY. Lin J, et al. Front Genet. 2022 Oct 17;13:1020757. doi: 10.3389/fgene.2022.1020757. eCollection 2022. Front Genet. 2022. PMID: 36324511 Free PMC article.

9

Therapeutic effect of targeted Fas-expressing adenoviruses method combining γδ T cells in a mouse model of human ovarian carcinoma.

Zeng D, Lin J, He H, Tan G, Lan Y, Jiang F, Sheng S. Zeng D, et al. Oncol Lett. 2018 Feb;15(2):2555-2561. doi: 10.3892/ol.2017.7599. Epub 2017 Dec 13. Oncol Lett. 2018. PMID: 29434973 Free PMC article.

10

How to enhance the applicability of a risk prediction model for term small-for-gestational-age neonates in clinical settings?

Kong SM, Gao C, Yu A, Lin SS, Wei DM, Wang CR, Lu JH, Zeng DY, Zhang J, He JR, Qiu X. Kong SM, et al. Int J Gynaecol Obstet. 2024 Jun;165(3):1104-1113. doi: 10.1002/ijgo.15268. Epub 2023 Dec 20. Int J Gynaecol Obstet. 2024. PMID: 38124502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,935 results

Search Page

Filters